Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance.
about
Aberrant insulin signaling in Alzheimer's disease: current knowledgeCocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension.The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertensionLiver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionComparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys.Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction.Insulin resistance, metabolic stress, and atherosclerosis.Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart FailureDifferential metabolic actions of specific statins: clinical and therapeutic considerationsToll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulinDehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion.Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humansRole of mitochondrial dysfunction in insulin resistance.Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stressTreatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats.Vascular actions of insulin with implications for endothelial dysfunction.Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment.Skeletal Muscle Vascular Function: A Counterbalance of Insulin Action.Endothelial dysfunction and vascular disease - a 30th anniversary update.Hyperinsulinemic-euglycemic clamp in the conscious ratThe PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.Surrogate measures of insulin resistance: of rats, mice, and men.Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats.Blood pressure normalization via pharmacotherapy improves cutaneous microvascular function through NO-dependent and NO-independent mechanisms.Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn.EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs)Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiologyRosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats
P2860
Q27024222-67CD04DF-53E2-461B-BFC9-2BFF2E064C9CQ30434226-F3EA9B1E-B4F5-4171-987A-7FD482AE5D6AQ33566754-A4F3E057-72E5-42E1-AB0E-1A462A60A14BQ33577496-A7E15001-150B-4530-BCDC-7C727F10BD4AQ33810041-7F217263-638E-42AC-A562-0AF152808812Q34171384-DA6C457C-0CE2-41B4-9ECB-40E22FA73E6DQ34231611-A598EEF3-7F5C-47C9-91F7-BE7C4341E93FQ34566602-54260E0A-6FAA-4B81-BE92-39F0A3759693Q34894220-77DE7A6C-B7EB-43DD-AECD-1489D1D7D107Q35608658-E16D7CBA-ADCA-46AD-9CC2-7F6005FC6D4DQ35707124-C0FD5955-EA1B-4D42-853D-12B2B7FF95BDQ35871387-B17F8C54-8994-4795-9822-61056179A657Q35924401-76B77F1A-52C6-460D-90E1-F5000DD73965Q36367130-D16349AE-3EC3-43B8-9833-8377D02864A2Q36406951-57CBB382-87BB-4B39-ABF8-4AAB4DA5F6A1Q36836199-1B8461CB-0A50-4FE1-A9DA-CD8298C66315Q36944784-D6BA15BA-5778-4243-AD1C-99598AAA4E0FQ37016686-54BD52C4-5851-4ED1-B387-9FEB517D13CBQ37097807-3D6516FD-6808-4912-8560-F208A7F68886Q37106691-22C21ACD-9A20-4F60-A4C5-F846F766C092Q37175490-A9FC6FAB-59A2-4A77-9DD8-BD9B64B08796Q37337305-F471A6D8-9D3C-428D-8A07-164B4A932ED6Q37430821-15BD5038-74A8-4742-BF4D-F19AC83EADFBQ37505788-DE197152-8899-4975-9EBE-D5E9220F6D74Q38102733-2E9F5D3B-FE51-4641-A489-6D4FFE60E9D2Q38436848-FE411FA2-07A5-4EBC-9ECC-CD2F6FCBDFE2Q38680112-80B55A4E-0714-483B-9AA9-5338116AEB3EQ38763721-521A793B-8636-4C6C-8554-BB2F8445CAC3Q39684983-C7B45B59-9D0E-4B4E-8B99-CE4C331689DFQ46145603-059C64DE-5FE1-49A6-A43E-F6337E8C1FADQ46739201-818629FE-D82A-4CE0-87F8-CBF0999ED0C4Q46906334-4CFA665E-7C64-4E02-90A1-194874F87E09Q48135874-24DDDD7E-1274-4932-BF9C-85E8F1CFDE17Q50693400-3BD361FE-B311-4214-8989-02EC0C7E909CQ50701193-3DB4CA61-F0BD-46CD-82C2-E732C9209612Q58229695-E6847350-465E-4115-9266-7CE5976DF3F7Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189Q58229743-8E6F3A28-0F99-4405-BEB0-42B4F3D6B733
P2860
Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Treatment of spontaneously hyp ...... ension and insulin resistance.
@en
Treatment of spontaneously hyp ...... ension and insulin resistance.
@nl
type
label
Treatment of spontaneously hyp ...... ension and insulin resistance.
@en
Treatment of spontaneously hyp ...... ension and insulin resistance.
@nl
prefLabel
Treatment of spontaneously hyp ...... ension and insulin resistance.
@en
Treatment of spontaneously hyp ...... ension and insulin resistance.
@nl
P2093
P356
P1433
P1476
Treatment of spontaneously hyp ...... ension and insulin resistance.
@en
P2093
Flora L Marasciulo
Mariela Tarquinio
Monica Montagnani
P304
P356
10.2337/DB06-0667
P407
P577
2006-12-01T00:00:00Z